4//SEC Filing
GLASSPOOL JOHN 4
Accession 0001213900-22-029835
CIK 0001553643other
Filed
May 25, 8:00 PM ET
Accepted
May 26, 6:41 PM ET
Size
5.9 KB
Accession
0001213900-22-029835
Insider Transaction Report
Form 4
GLASSPOOL JOHN
Director
Transactions
- Award
Stock Option (right to buy)
2022-05-25+91,235→ 150,000 totalExercise: $19.03From: 2022-03-17Exp: 2031-12-17→ Common Stock (91,235 underlying)
Footnotes (2)
- [F1]The option grant was approved by the Board of Directors of the Company on December 17, 2021, subject to shareholder approval of an amendment to the Company's 2021 Equity Incentive Plan (the "Plan") increasing the number of shares of Common Stock available for the grant of awards under the Plan in an amount sufficient to cover this option grant. Shareholder approval was received for such amendment on May 25, 2022, at the 2022 Annual Meeting of the Company's shareholders.
- [F2]The option vests in 16 equal quarterly installments, at 6.25% per quarter, commencing on March 17, 2022.
Documents
Issuer
RELMADA THERAPEUTICS, INC.
CIK 0001553643
Entity typeother
Related Parties
1- filerCIK 0001644079
Filing Metadata
- Form type
- 4
- Filed
- May 25, 8:00 PM ET
- Accepted
- May 26, 6:41 PM ET
- Size
- 5.9 KB